Talphera (TLPH) Net Equity Issued and Repurchased (2010 - 2023)
Talphera (TLPH) posted quarterly Net Equity Issued and Repurchased of -$68000.0 for Q4 2023, down 134.0% quarter-over-quarter from $200000.0 in Q3 2022.
Talphera (TLPH) Net Equity Issued and Repurchased (2010 - 2023) Analysis & Trends
Talphera's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at -$68000.0 for Q4 2023.
- In Q4 2023, Net Equity Issued and Repurchased changed N/A year-over-year to -$68000.0; the TTM figure through Dec 2024 stood at $132000.0 (changed 0.0% YoY), while the FY2023 annual figure was $8.9 million, up 3605.44% from the prior year.
- Net Equity Issued and Repurchased for Q4 2023 stood at -$68000.0, down from $200000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $36.4 million in Q1 2021, with the low at -$36.4 million in Q3 2021.
- The 5-year median for Net Equity Issued and Repurchased is $1.0 million (2019), against an average of $3.0 million.
- Peak annual rise in Net Equity Issued and Repurchased reached 4537.76% in 2021, while the deepest fall reached 465.39% in 2021.
- Talphera's Net Equity Issued and Repurchased stood at $1.2 million in 2019, then soared by 705.92% to $9.9 million in 2020, then sank by 465.91% to -$36.4 million in 2021, then surged by 100.55% to $200000.0 in 2022, then plunged by 134.0% to -$68000.0 in 2023.
- Business Quant data shows TLPH's Net Equity Issued and Repurchased at -$68000.0 in Q4 2023, $200000.0 in Q3 2022, and -$36.4 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -68,000.00 |
| Dec 31, 2023 | -68,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Sep 30, 2021 | -36.36 Mn |
| Sep 30, 2021 | -36.36 Mn |
| Jun 30, 2021 | 7.50 Mn |
| Jun 30, 2021 | 7.50 Mn |
| Mar 31, 2021 | 36.36 Mn |
| Mar 31, 2021 | 36.36 Mn |
| Dec 31, 2020 | 9.94 Mn |
| Dec 31, 2020 | 9.94 Mn |
| Sep 30, 2020 | 9.95 Mn |
| Sep 30, 2020 | 9.95 Mn |
| Jun 30, 2020 | 665,000.00 |
| Jun 30, 2020 | 665,000.00 |
| Mar 31, 2020 | 784,000.00 |
| Mar 31, 2020 | 784,000.00 |
| Sep 30, 2019 | 1.23 Mn |
| Sep 30, 2019 | 1.23 Mn |